Results

Results

The 2020 AMR Benchmark compares what 30 pharmaceutical companies are doing to help bring antimicrobial resistance under control. Its assessment is based on a framework of 19 metrics across three Research Areas. Here you find the four key findings from 2020 as well as analyses of the companies' antimicrobial portfolios.

Get in touch

Back to top |